Healthcare Losers: Dendreon Corporation (NASDAQ:DNDN), Atossa Genetics Inc (NASDAQ:ATO), Acura Pharmaceuticals (NASDAQ:ACUR), Gentiva Health Services (NASDAQ:GTIV)

Shares of Dendreon Corp. (NASDAQ:DNDN) saw unusually large options trading activity on Monday. Stock investors purchased 6,345 put options on the stock, American Banking and Market News reports. Dendreon Corporation (NASDAQ:DNDN) rose percent to $14.93 yesterday on volume of 25.95 million shares. The intra-day range of the stock was $3.11 to $3.46. Dendreon Corporation (NASDAQ:DNDN) has a market capitalization of $521.28 million. Dendreon Corporation (NASDAQ:DNDN) stock opened at $3.24 in last session, and closed at $3.07, while the day range of DNDN stock is $3.03-$3.28.The stock showed a positive weekly performance of 2.68%.

Atossa Genetics Inc. (NASDAQ:ATOS) has reported that the US Food and Drug Administration, the federal regulatory body, has sought more information and data to further review an application for a breast aspirator called ForeCYTE, developed by ATOS. Atossa Genetics Inc (NASDAQ:ATO) stock opened at $1.85, in last session and closed at $1.88, by loosed -11.32%.The 52 week range was $1.74-$12.40.Company’s market capitalization is $33.89 million.

Acura Pharmaceuticals (NASDAQ:ACUR) issued its quarterly earnings data on Monday. The company reported ($0.29) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.06) by $0.23, Analyst RN reports. Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) stock loosed -7.61% and finished the last session at $1.82.The EPS of the stock remained -0.29.Company’s market capitalization is $87.95 million.

Gentiva Health Services (NASDAQ:GTIV) dropped 11.8% during mid-day trading on Tuesday following a dissappointing earnings announcement,Analyst Ratings News reports. Gentiva Health Services, Inc. (NASDAQ:GTIV) stock opened the session at $10.61, and closed the session at $9.74.The 52 week range of the GTIV stock remained $8.47-$13.85 and the day range was $9.28-$10.61.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *